Trial intelligence / Profile preview

16-hour fasting plus serplulimab and CAPEOX as neoadjuvant therapy for pMMR/MSS locally advanced mid-to-low rectal cancer

ChiCTR2600131976Phase 2Not yet recruiting

Sponsor

Second Affiliated Hospital of Zhejiang University School of Medicine

Start

Jun 2026

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules

Countries

1